CiRT Consortium

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	cirt-net.org
NAICS	541714
Keywords	Inkt And Immunotherapy
Employees	1-10

Key Contact at CiRT Consortium

Antonia Rotolo

Co-Founder

CiRT Consortium Email Formats

CiRT Consortium uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cirt-net.org), used 60% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cirt-net.org	60%
{first initial}.{last name}	j.doe@cirt-net.org	40%

About CiRT Consortium

The Consortium for iNKT Research and Therapy (CiRT) is a coalition of investigators with interests in iNKT research and clinical translation. The CiRT aims to further the development of iNKT-based technologies, including cell and gene therapies to improve the outcomes of cancers, organ and bone marrow transplantation, infectious diseases and autoimmune disorders.

CiRT Consortium revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding